title: Effects of macrophage-activating lipopeptide-2 (MALP-2) on the vascularisation of implanted polyurethane scaffolds seeded with microvascular fragments.
abstract: The seeding of scaffolds with adipose tissue-derived microvascular fragments represents a promising strategy to establish a sufficient blood supply in tissue constructs. Herein, we analysed whether a single application of macrophage-activating lipopeptide-2 (MALP-2) at the implantation site further improves the early vascularisation of such microvessel-seeded constructs. Microvascular fragments were isolated from epididymal fat pads of C57BL/6 mice. The fragments were seeded on polyurethane scaffolds, which were implanted into mouse dorsal skinfold chambers exposed to MALP-2 or vehicle (control). The inflammatory host tissue response and the vascularisation of the scaffolds were analysed using intravital fluorescence microscopy, histology and immunohistochemistry. We found that the numbers of microvascular adherent leukocytes were significantly increased in MALP-2-treated chambers during the first 3 days after scaffold implantation when compared to controls. This temporary inflammation resulted in an improved vascularisation of the host tissue surrounding the implants, as indicated by a higher density of CD31-positive microvessels at day 14. However, the MALP-2-exposed scaffolds themselves presented with a lower functional microvessel density in their centre. In addition, in vitro analyses revealed that MALP-2 promotes apoptotic cell death of endothelial and perivascular cells in isolated microvascular fragments. Hence, despite the beneficial pro-angiogenic properties of MALP-2 at the implantation site, the herein evaluated approach may not be recommended to improve the vascularisation capacity of microvascular fragments in tissue engineering applications.
authors.affiliation: Institute for Clinical & Experimental Surgery, Saarland University, D-66421 Homburg/Saar, Germany.matthias.laschke@uks.eu.
authors.forename: C
authors.initials: C
authors.lastname: Grässer
authors.forename: C
authors.initials: C
authors.lastname: Scheuer
authors.forename: J
authors.initials: J
authors.lastname: Parakenings
authors.forename: T
authors.initials: T
authors.lastname: Tschernig
authors.forename: D
authors.initials: D
authors.lastname: Eglin
authors.forename: M D
authors.initials: MD
authors.lastname: Menger
authors.forename: M W
authors.initials: MW
authors.lastname: Laschke
mesh_terms: D000818:Animals; D053148:Caspase 3 / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007150:Immunohistochemistry; D020007:Implants, Experimental; D007249:Inflammation / Q000473:pathology; D055666:Lipopeptides / Q000494:pharmacology*; D008297:Male; D008810:Mice, Inbred C57BL; D008856:Microscopy, Fluorescence; D055806:Microvessels / Q000187:drug effects / Q000502:physiology*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011140:Polyurethanes / Q000494:pharmacology*; D054457:Tissue Scaffolds / Q000737:chemistry*
chemical_list: D055666:Lipopeptides; D011140:Polyurethanes; C106335:macrophage stimulatory lipopeptide 2; D053148:Caspase 3